Bull & Lifshitz, LLP Announces Investigation of Pharmaceutical Product Development, Inc.
October 27 2011 - 9:48AM
Business Wire
Bull & Lifshitz, LLP announces an investigation into
possible breaches of fiduciary duty in connection with the proposed
sale of Pharmaceutical Product Development, Inc. (NASDAQ: PPDI)
(referred to as "PPD" or the “Company”) to affiliates of The
Carlyle Group ("Carlyle") and Hellman & Friedman LP (“Hellman
& Friedman”) in a cash transaction valued at approximately $3.9
billion.
Under the terms of the agreement, Carlyle and Hellman &
Friedman will acquire all of the outstanding common shares of PPD
for $33.25 per share in cash. The transaction is currently expected
to close in the fourth quarter of 2011.
Bull & Lifshitz, LLP's investigation is focused on whether
the proposed deal provides adequate value to the Company’s
shareholders.
If you are a holder of PPD common stock and want to discuss your
legal rights, you may e-mail or call Bull & Lifshitz, LLP who
will, without obligation or cost to you, attempt to answer your
questions.
If you are a shareholder of PPD and would like more information
about our investigation, please contactJoshua M. Lifshitz, Esq. by
telephone at (866) 313-6222 or by sending an e-mail including your
contact information to: counsel@nyclasslaw.com. All e-mail
correspondence should make reference to PPD.
Bull & Lifshitz, LLP is a New York City-based law firm with
significant experience representing investors in merger-related
shareholder class actions, shareholder derivative actions, and
securities fraud class actions. For more information about the
firm, please visit our website at www.nyclasslaw.com.
ATTORNEY ADVERTISING. © 2011 Bull & Lifshitz, LLP.
The law firm responsible for this advertisement is Bull &
Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212)
213-6222. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From Apr 2023 to Apr 2024
